Why EU FMD alert handling issues Happens in Serialization & Track-and-Trace and How to Fix It


Published on 17/06/2026

Understanding Handling Issues in Serialization and Track-and-Trace Systems for EU FMD Compliance

The pharmaceutical industry faces ongoing challenges with serialization and track-and-trace systems, particularly when adhering to EU Falsified Medicines Directive (FMD) requirements. This case study examines a real-world scenario involving aggregation errors within a pharmaceutical manufacturing facility and outlines the methodology for detection, containment, investigation, and corrective actions. By the end of this article, readers will be better equipped to identify handling issues, implement effective corrective and preventive actions (CAPA), and enhance their inspection readiness.

Serialization and track-and-trace are critical components in ensuring the safety and authenticity of medicinal products while complying with regulatory requirements such as DSCSA in the US and EU FMD. Robust handling and management of these systems are paramount for operational excellence in the pharmaceutical industry.

Symptoms/Signals on the Floor or in the Lab

In our case study, the signal that prompted investigation was an unexpectedly high number of discrepancies reported during a routine reconciliation process involving serialization data. Specifically, team members noted:

  • An increase in aggregation errors, where the aggregated serial
numbers on higher-level packaging did not match the expected lower-level serial numbers.
  • Frequent worker reports of system-generated alerts regarding serialization inconsistencies.
  • Unauthorized discrepancies logged in the track-and-trace system, suggesting data integrity issues.
  • These issues indicated potential flaws in the serialization track-and-trace process, potentially jeopardizing compliance with EU FMD regulations. Consistent monitoring and data validation are essential to swiftly identify such symptoms before they escalate into more significant compliance risks.

    Likely Causes (by category: Materials, Method, Machine, Man, Measurement, Environment)

    Upon initial review, the following categories were considered to identify likely causes of the serialization issues:

    Category Potential Causes
    Materials Incorrect labels applied to packaging materials leading to erroneous aggregation data.
    Method Inadequate operational procedures for handling serialization information could lead to data-entry errors.
    Machine Malfunctions in the serialization printing equipment resulting in unreadable or missing serial numbers.
    Man Training gaps among staff on serialization processes, leading to misunderstanding or misuse of the system.
    Measurement Inaccurate scanning processes due to improperly calibrated equipment.
    Environment Issues such as ambient lighting affecting barcode scanning efficiency.

    This comprehensive approach to understanding potential causes enables targeted investigation efforts which can mitigate the occurrence of aggregation errors and improve compliance with regulatory standards.

    Immediate Containment Actions (first 60 minutes)

    Once the aggregation errors were detected, immediate actions were taken to contain the situation and prevent further discrepancies. Key actions included:

    1. Stop Production: Cease all packaging operations to prevent additional serialization discrepancies.
    2. Isolate Affected Products: Halt distribution of all products identified with potential aggregation errors and quarantine them pending investigation.
    3. System Lockdown: Temporarily lock the serialization track-and-trace system to prevent further entries or modifications until the root cause could be identified.
    4. Notify Relevant Staff: Inform all personnel involved in the serialization and quality assurance processes to ensure immediate alignment and focused response efforts.

    Implementing these immediate actions serves to limit the risks associated with erroneous data and maintain regulatory compliance.

    Investigation Workflow (data to collect + how to interpret)

    Following containment, a thorough investigation was initiated to identify the root cause of the aggregation errors. The investigation workflow involved:

    • Data Collection: Gather all relevant serialization data, including batch records, scanning logs, machine performance logs, and incident reports.
    • Interviews: Conduct interviews with operators and personnel involved in the serialization process to gather qualitative data and firsthand accounts of the operational workflow.
    • Observation: Observe the serialization process firsthand to identify potential discrepancies in practice versus documented procedures.

    Data interpretation focused on correlating discrepancies in aggregation with specific operational steps, identifying patterns of error, and recognizing training deficiencies among personnel handling serialization tasks. Careful analysis of this collected data provided insights into the direct causes of the observed discrepancies.

    Root Cause Tools (5-Why, Fishbone, Fault Tree) and when to use which

    To effectively identify root causes of the serialization issues, various analytical tools were employed:

    • 5-Why Analysis: This tool was used to drill down into the immediate causes. By repeatedly asking “Why?” the investigation team was able to reveal deeper underlying issues, such as a lack of training.
    • Fishbone Diagram (Ishikawa): Employed to categorize potential causes and visualize relationships between causes, the Fishbone diagram clarified the impact of human factors, machine issues, and methods on aggregation failures.
    • Fault Tree Analysis: This tool evaluated specific failures of individual components within the serialization machinery and their relationships to overall system errors.

    Each of these tools provided unique insights. The 5-Why analysis highlighted training deficiencies, while Fishbone diagrams brought attention to broader systemic issues. Fault Tree Analysis provided a technical layer of understanding, elucidating equipment failures and their cascading effects. Using a combination of these tools resulted in a comprehensive understanding of root causes.

    CAPA Strategy (correction, corrective action, preventive action)

    The CAPA strategy focused on three key components: correction, corrective action, and preventive action.

    • Correction: Immediately, erroneous serialization data were corrected, and verification was initiated to ensure integrity in the track-and-trace system.
    • Corrective Action: Root causes identified included inadequate training and systemic workflow gaps. A comprehensive retraining program was developed for all personnel involved in serialization processing to ensure understanding and compliance with procedures.
    • Preventive Action: Implementation of a continuous improvement program was established, focusing on regular training updates and periodic audits of serialization procedures to prevent future discrepancies.

    This structured CAPA strategy ensures that not only are immediate issues addressed, but systemic problems are resolved, enhancing long-term compliance and operational integrity.

    Control Strategy & Monitoring (SPC/trending, sampling, alarms, verification)

    An effective control strategy is crucial for monitoring serialization track-and-trace activities moving forward. Key aspects of this strategy include:

    • Statistical Process Control (SPC): Utilizing SPC techniques, including control charts, helps in monitoring serialization processes for signs of variation and potential faults.
    • Real-Time Sampling: Streamlined sampling methods for quality checks on serialized products helped in maintaining immediate oversight of serialization accuracy during production.
    • Alarm Systems: Integration of automated alert systems within the track-and-trace systems ensures immediate notification of discrepancies as they arise, allowing for rapid intervention.
    • Verification Processes: Regular audits and verification checks of serialized batches against their tracking data ensured compliance, with a clear record maintained for regulatory review.

    By implementing robust control strategies, the risk of future serialization discrepancies can be significantly reduced while enhancing regulatory compliance and operational efficiency.

    Related Reads

    Validation / Re-qualification / Change Control impact (when needed)

    It is essential to consider the impacts on validation, re-qualification, and change control processes as part of the investigation and CAPA. Here’s how these elements intersect:

    • Validation: Any changes made to serialization processes or systems require robust validation to ensure they function as intended and meet regulatory criteria consistently.
    • Re-qualification: If equipment changes or significant process adjustments were implemented, re-qualification protocols should be enacted to establish compliance with FDA or EMA standards.
    • Change Control: A formal change control process should be integrated to document and assess changes in serialization procedures, ensuring that any adjustments are thoroughly evaluated for impact to other operations.

    Addressing these elements timely fosters a transparent approach to regulatory compliance while enhancing process reliability.

    Inspection Readiness: what evidence to show (records, logs, batch docs, deviations)

    Maintaining inspection readiness is important, especially in high-stakes environments like pharmaceutical serialization. Several key documents are critical in demonstrating compliance:

    • Records and Logs: Comprehensive records of serialization data, including entry logs, aggregation checks, and system performance, must be maintained and readily accessible.
    • Batch Documentation: Accurate batch records showing detailed serialization processes, including serial number generation, application, and validation methods, contribute to inspection readiness.
    • Deviation Reports: Proper documentation of all deviations from expected procedural outcomes ensures transparency and accountability, which are critical during regulatory inspections.

    By establishing a culture of documentation maintenance and recordkeeping, organizations can enhance their readiness for audits and inspections, ultimately ensuring compliance with serialization and track-and-trace regulations.

    FAQs

    What is serialization in the pharmaceutical industry?

    Serialization refers to the process of assigning unique serial numbers to products for tracking and tracing within the supply chain to enhance security and compliance.

    How does the EU FMD impact pharmaceutical companies?

    The EU FMD mandates that pharmaceutical companies implement serialization systems to verify the authenticity of medicines and prevent counterfeit drugs from entering the supply chain.

    What can cause aggregation errors in serialization?

    Aggregation errors can arise from improper labeling, data entry mistakes, equipment malfunctions, and training deficiencies among personnel involved in serialization processes.

    Why is CAPA important in the serialization process?

    CAPA helps identify root causes of errors, implement corrective measures, and establish preventive actions, aiding organizations in maintaining compliance and improving processes.

    How do I ensure my serialization system is compliant?

    Continuous monitoring, regular training for personnel, and maintaining thorough documentation of processes and discrepancies are critical for ensuring compliance with serialization regulations.

    When should I conduct a root cause analysis?

    Root cause analysis should be conducted any time significant errors, discrepancies, or compliance risks are identified within serialization processes to uncover the underlying issues.

    What is SPC, and why is it important?

    Statistical Process Control (SPC) leverages statistical methods to monitor and control processes, minimizing variation and ensuring consistent product quality and compliance.

    What roles do audits play in serialization effectiveness?

    Regular audits ensure that serialization processes are effectively implemented, highlight areas for improvement, and maintain compliance with regulatory standards.

    How does training impact serialization accuracy?

    Training equips personnel with the necessary skills and knowledge to correctly manage serialization tasks, preventing errors and ensuring regulatory compliance.

    What is change control in serialization?

    Change control is a systematic approach to managing changes within processes that can impact product quality and compliance, ensuring proper documentation and evaluation.

    How can manufacturers prepare for regulatory inspections?

    By maintaining comprehensive documentation, conducting regular training, and implementing robust monitoring and control strategies, manufacturers can prepare effectively for inspections.

    How do you manage serialization data integrity?

    Maintaining data integrity involves rigorous data validation, real-time monitoring, error tracking, and routine reviews of serialization data against tracking systems.

    If you find our Articles useful
    Add us as preferred source on Google
    Pharma Tip:  How to Use KPIs to Detect EU FMD alert handling issues in Serialization & Track-and-Trace
    If you find our Articles useful
    Add us as preferred source on Google